Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer

Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer

US Patent 10301685 · Granted May 28, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of using biomarkers and clinical variables for predicting chemotherapy be2024
Method for breast cancer recurrence prediction under endocrine treatment2024
Method for breast cancer recurrence prediction under endocrine treatment2024
Method of using biomarkers and clinical variables for predicting chemotherapy be2022
Method for breast cancer recurrence prediction under endocrine treatment2020
Method for breast cancer recurrence prediction under endocrine treatment2020
Method for breast cancer recurrence prediction under endocrine treatment2020
Method for breast cancer recurrence prediction under endocrine treatment2020
Method for predicting therapy responsiveness in basal like tumors2018
Liver disease-related methods and systems2010
Monoclonal antibody and assay for detecting PIIINP2009
Method and device for investigating substance libraries2008